1. Home
  2. Labeler Index
  3. Zevra Therapeutics, Inc.
  4. 70040-0167
  5. NDC Package Code: 70040-0167-1 Apadaz

NDC Package 70040-0167-1 Apadaz

Benzhydrocodone And Acetaminophen Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70040-0167-1
Package Description:
100 TABLET in 1 BOTTLE, PLASTIC
Product Code:
70040-0167
Proprietary Name:
Apadaz
Non-Proprietary Name:
Benzhydrocodone And Acetaminophen
Substance Name:
Acetaminophen; Benzhydrocodone Hydrochloride
Usage Information:
APADAZ is contraindicated in patients with:Significant respiratory depression [see Warnings and Precautions (5.3)]Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see Warnings and Precautions (5.8)]Known or suspected gastrointestinal obstruction, including paralytic ileus [see Warnings and Precautions (5.14)]Hypersensitivity to hydrocodone or acetaminophen, or any other component of this product (e.g., anaphylaxis) [see Warnings and Precautions (5.13), Adverse Reactions (6)]
11-Digit NDC Billing Format:
70040016701
NDC to RxNorm Crosswalk:
  • RxCUI: 2001358 - benzyhydrocodone 6.12 MG / acetaminophen 325 MG Oral Tablet
  • RxCUI: 2001358 - acetaminophen 325 MG / benzhydrocodone 6.12 MG Oral Tablet
  • RxCUI: 2001358 - acetaminophen 325 MG / benzhydrocodone 6.12 MG (as benzhydrocodone HCl 6.67 MG) Oral Tablet
  • RxCUI: 2001358 - APAP 325 MG / benzhydrocodone 6.12 MG Oral Tablet
  • RxCUI: 2001364 - apadaz 6.12 MG / 325 MG Oral Tablet
Product Type:
Human Prescription Drug
Labeler Name:
Zevra Therapeutics, Inc.
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
DEA Schedule:
Schedule II (CII) Substances
Sample Package:
No
FDA Application Number:
NDA208653
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
02-23-2018
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70040-0167-1?

The NDC Packaged Code 70040-0167-1 is assigned to a package of 100 tablet in 1 bottle, plastic of Apadaz, a human prescription drug labeled by Zevra Therapeutics, Inc.. The product's dosage form is tablet and is administered via oral form.

Is NDC 70040-0167 included in the NDC Directory?

Yes, Apadaz with product code 70040-0167 is active and included in the NDC Directory. The product was first marketed by Zevra Therapeutics, Inc. on February 23, 2018 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70040-0167-1?

The 11-digit format is 70040016701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170040-0167-15-4-270040-0167-01